- Home
- SIM vs CRNX Comparison
SIM vs CRNX Comparison
Compare SIM & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SIM | CRNX |
|---|---|---|
| Founded | 1969 | 2008 |
| Country | Mexico | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.1B |
| IPO Year | 1993 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SIM | CRNX |
|---|---|---|
| Price | $31.48 | $47.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $75.78 |
| AVG Volume (30 Days) | 2.2K | ★ 1.4M |
| Earning Date | 02-27-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.94 | N/A |
| Revenue | ★ $1,698,258,820.00 | $1,535,000.00 |
| Revenue This Year | N/A | $499.13 |
| Revenue Next Year | N/A | $893.14 |
| P/E Ratio | $33.39 | ★ N/A |
| Revenue Growth | N/A | ★ 47.74 |
| 52 Week Low | $22.15 | $24.10 |
| 52 Week High | $34.59 | $57.99 |
Technical Indicators
Market Signals| Indicator | SIM | CRNX |
|---|---|---|
| Relative Strength Index (RSI) | 59.23 | 37.19 |
| Support Level | $27.51 | $50.84 |
| Resistance Level | $30.51 | $50.57 |
| Average True Range (ATR) | 0.65 | 2.25 |
| MACD | 0.14 | -0.97 |
| Stochastic Oscillator | 96.48 | 3.43 |
Price Performance
Historical ComparisonAbout SIM Grupo Simec S.A.B. de C.V.
Grupo Simec SAB de CV is a diversified producer, processor and distributor of SBQ steel and structural steel products with production and commercial operations. The group's SBQ products are used across a range of engineered end-user applications, including axles, hubs, and crankshafts for automobiles and light trucks, machine tools, and off-highway equipment. Its structural steel products are used in the non-residential construction market and other construction applications. Its segments are Mexico, Brazil, and the United States. The maximum of its sales is from the Mexico segment.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.